Phase I study of daily and weekly regimens of the orally administered MDM2 antagonist idasanutlin in patients with advanced tumors
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-0646
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Phase I study of daily and weekly regimens of the orally administered MDM2 antagonist idasanutlin in patients with advanced tumors ; day:28 ; month:6 ; year:2021 ; pages:1-11
Investigational new drugs ; (28.6.2021), 1-11
- Urheber
-
Italiano, Antoine
Miller, Wilson H.
Blay, Jean-Yves
Gietema, Jourik A.
Bang, Yung-Jue
Mileshkin, Linda R.
Hirte, Hal W.
Higgins, Brian
Blotner, Steven
Nichols, Gwen L.
Chen, Lin Chi
Petry, Claire
Yang, Qi Joy
Schmitt, Christophe
Jamois, Candice
Siu, Lillian L.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s10637-021-01141-2
- URN
-
urn:nbn:de:101:1-2021101019065588254849
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:38 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Italiano, Antoine
- Miller, Wilson H.
- Blay, Jean-Yves
- Gietema, Jourik A.
- Bang, Yung-Jue
- Mileshkin, Linda R.
- Hirte, Hal W.
- Higgins, Brian
- Blotner, Steven
- Nichols, Gwen L.
- Chen, Lin Chi
- Petry, Claire
- Yang, Qi Joy
- Schmitt, Christophe
- Jamois, Candice
- Siu, Lillian L.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Absorption of orally administered enzymes
Orally administered nanoparticles for gastrointestinal applications
Human Pharmacokinetics of Orally Administered (24 R)-Hydroxycalcidiol
Effect of orally administered moxaverine on ocular haemodynamics
Metabolic fate of orally administered cGMP in rats
A Microstirring Pill Enhances Bioavailability of Orally Administered Drugs
Orally Administered Amoxicillin/Clavulanate: Current Role in Outpatient Therapy
Orally administered oxygen nanobubbles enhance tumor response to sonodynamic therapy
Gallbladder hemorrhage during orally administered edoxaban therapy: a case report
Orally administered endoxifen inhibits tumor growth in melanoma-bearing mice
Long-Term Follow-Up of Orally Administered Diacetylmorphine Substitution Treatment
Effects of orally administered Clenbuterol on oxytocin-induced uterine activity
Absorption of orally administered enzymes
Orally administered nanoparticles for gastrointestinal applications
Human Pharmacokinetics of Orally Administered (24 R)-Hydroxycalcidiol
Effect of orally administered moxaverine on ocular haemodynamics
Metabolic fate of orally administered cGMP in rats
A Microstirring Pill Enhances Bioavailability of Orally Administered Drugs
Orally Administered Amoxicillin/Clavulanate: Current Role in Outpatient Therapy
Orally administered oxygen nanobubbles enhance tumor response to sonodynamic therapy
Gallbladder hemorrhage during orally administered edoxaban therapy: a case report
Orally administered endoxifen inhibits tumor growth in melanoma-bearing mice
Long-Term Follow-Up of Orally Administered Diacetylmorphine Substitution Treatment
Effects of orally administered Clenbuterol on oxytocin-induced uterine activity
Absorption of orally administered enzymes
Orally administered nanoparticles for gastrointestinal applications
Human Pharmacokinetics of Orally Administered (24 R)-Hydroxycalcidiol
Effect of orally administered moxaverine on ocular haemodynamics
Metabolic fate of orally administered cGMP in rats
A Microstirring Pill Enhances Bioavailability of Orally Administered Drugs
Orally Administered Amoxicillin/Clavulanate: Current Role in Outpatient Therapy
Orally administered oxygen nanobubbles enhance tumor response to sonodynamic therapy
Gallbladder hemorrhage during orally administered edoxaban therapy: a case report
Orally administered endoxifen inhibits tumor growth in melanoma-bearing mice
Long-Term Follow-Up of Orally Administered Diacetylmorphine Substitution Treatment